Exosome Diagnostics And Therapeutics Market Size
Exosome Diagnostics and Therapeutics Market Size was valued at US$ 89.2 million in 2024 and is expected to grow at a CAGR of 10.3% to reach US$ 217.6 million by 2034
Exosome Diagnostics and Therapeutics refers to using exosomes, which are small extracellular vesicles generated by cells, for diagnostic and therapeutic purposes in healthcare. The ability of exosomes to transfer lipids, proteins, and nucleic acids across cells makes them crucial for intercellular communication. In diagnostics, exosomes are being studied as possible biomarkers for many illnesses, including cancer, neurological disorders, and cardiovascular diseases. It is possible to isolate and analyze exosomes from biofluids like blood, urine, or cerebrospinal fluid to identify specific molecular markers associated with illnesses. Monitoring the course of a disease and making early diagnoses may benefit from this.
Exosomes' innate homing abilities and ability to cross biological barriers have led to research on them as natural drug delivery vehicles for therapeutic purposes, by creating exosomes, therapeutic materials such as proteins, nucleic acids, or small chemicals can be delivered to target cells or tissues in a targeted manner. As a result, treatments may be more effective and have fewer unintended side effects.